Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: angina major surgical or invasive procedure: cabg x3 (lima to lad, svg to om, svg to pda) history of present illness: 64 yo male with cad and prior ptca years ago. transferred in from osh with unstable angina and + mibi for infero-septal ischemia. cardiac enzymes were negative x 2. went home for plavix washout, to return for cabg in a few days. past medical history: htn hyperlipidemia cad /ptca ~15 yrs ago - balloon angioplasty social history: social history is significant for the absence of current tobacco use- quit 20 yrs ago. there is no history of alcohol abuse. family history: father died 69 with cerebral hemorrhage, mother died at 80 "old age". there is no family history of premature coronary artery disease or sudden death. physical exam: 5'9 " 212 # skin heent unremarkable neck supple , full rom, no carotid bruits appreciated ctab anteriorly rrr no murmur soft, nt, nd + bs warm, well-perfused with no edema or varicosities noted neruo grossly intact 2 + bil. fem/dp/pt/radials pertinent results: conclusions prebypass 1. the left atrium is normal in size. no atrial septal defect or pfo is seen by 2d or color doppler. 2. left ventricular wall thicknesses and cavity size are normal. 3. right ventricular chamber size and free wall motion are normal. 4. there are simple atheroma in the aortic arch. there are simple atheroma in the descending thoracic aorta. 5. the aortic valve leaflets (3) are mildly thickened. there is mild aortic valve stenosis (area 1.2-1.9cm2). no aortic regurgitation is seen. 6. the mitral valve leaflets are structurally normal. mild (1+) mitral regurgitation is seen. 7. there is no pericardial effusion. 8. dr. was notified in person of the results on at 928. post cpb: preserved -ventricular systolic function. no change in valve structure or function. i certify that i was present for this procedure in compliance with hcfa regulations. electronically signed by , md, interpreting physician 11:03 , j m 64 radiology report chest (portable ap) study date of 8:14 am , r. csurg csru sched chest (portable ap) clip # reason: ? ptx s/p ct removal medical condition: 64 year old man s/p cabg reason for this examination: ? ptx s/p ct removal provisional findings impression: sp 4:01 pm no pneumothorax after instrument removal. final report type of examination: chest ap portable single view. indication: status post bypass surgery. now extubated and tube removal. the patient is extubated and the previously described central venous line, pulmonary catheter, mediastinal and chest tubes have been removed. there is no pneumothorax and no significant pulmonary vascular congestion. when comparison is extended to the pre-operative single view study of , postoperative findings include moderate enlargement of the heart silhouette and some retrocardiac density consistent with atelectasis. no new acute parenchymal infiltrates are identified. dr. approved: 5:26 pm ?????? caregroup is. all rights reserved. 08:40am blood wbc-7.9 rbc-3.14* hgb-10.3* hct-28.4* mcv-91 mch-32.8* mchc-36.2* rdw-11.9 plt ct-187 12:15pm blood wbc-19.3*# rbc-3.69* hgb-12.1* hct-32.9* mcv-89 mch-32.6* mchc-36.6* rdw-12.6 plt ct-168 08:40am blood glucose-112* urean-13 creat-0.8 na-136 k-4.5 cl-103 hco3-26 angap-12 02:59am blood glucose-130* urean-13 creat-0.7 na-137 k-4.1 cl-107 hco3-26 angap-8 brief hospital course: admitted and underwent cabg x3 with dr. . please refer to dr operative report for further details. transferred to the cvicu in stable condition on phenyleprine and propofol drips. extubated later that afternoon. gently diuresed toward his preop weight. beta blockade titrated.tubes and drains were discontinued in a timely fashion. pod#1 he was transfered to sdu for further telemetry monitoring and recovery. the remainder of his postoperative course was essentially uneventful. he continued to progress and on pod#4 he was discharged to home with vna. all follow up appointments were advised. medications on admission: hctz 25 mg daily atenolol 75 mg lipitor 80 mg daily imdur 60 mg daily norvasc 2.5 mg daily folic acid discharge medications: 1. potassium chloride 20 meq packet sig: one (1) packet po q12h (every 12 hours) for 7 days. disp:*14 packet(s)* refills:*0* 2. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*0* 3. ranitidine hcl 150 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*0* 4. atorvastatin 80 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*0* 5. folic acid 1 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*0* 6. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*0* 7. oxycodone-acetaminophen 5-325 mg tablet sig: 1-2 tablets po q4h (every 4 hours) as needed. disp:*45 tablet(s)* refills:*0* 8. metoprolol tartrate 25 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*0* 9. lasix 20 mg tablet sig: one (1) tablet po twice a day for 7 days. disp:*14 tablet(s)* refills:*0* discharge disposition: home with service facility: . vna discharge diagnosis: cad s/p cabg x3 htn elev. lipids discharge condition: good discharge instructions: no lotions, creams or powders to any incision no lifting greater than 10 pounds for 10 weeks call for fever greater than 100.5, redness, or drainage no driving for one month and until off all narcotics shower daily and pat incisions dry followup instructions: see dr. in weeks see dr. in weeks see dr. in 4 weeks procedure: single internal mammary-coronary artery bypass extracorporeal circulation auxiliary to open heart surgery (aorto)coronary bypass of two coronary arteries diagnoses: acidosis other iatrogenic hypotension coronary atherosclerosis of native coronary artery intermediate coronary syndrome unspecified essential hypertension other and unspecified hyperlipidemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation 

Answer: The patient is high likely exposed to